India's Aarti Drugs down after Q3 profit, rev fall
** Shares of Aarti Drugs ADRG.NS drop nearly 5% to 508.9
rupees
** ADRG's Dec-qtr profit and revenue from operations both
down 14% y-o-y
** Says revenue from domestic market, 67% of total, declines
~4.5%
** If losses hold, stock on track to fall for six sessions
out of 19 so far this month
** Stock up nearly 4% YTD vs 4.4% rise in Nifty pharma index
.NIPHARM
(Reporting by Rama Venkat in Bengaluru)
((ramavenkat.raman@thomsonreuters.com; https://twitter.com/ramavenkat0607;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees